ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) owes 15-20% of all the invasive subtypes of breast cancer [4] and characterized by absence of expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER-2) on tumors cell membrane.